Free Trial

Voyager Therapeutics (VYGR) Earnings Date, Estimates & Call Transcripts

Voyager Therapeutics logo
$1.78 -0.05 (-2.74%)
As of 02:46 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Voyager Therapeutics Earnings Summary

Voyager Therapeutics released Q3 2026 earnings on November 5, 2026, reporting an EPS of -$0.40, which topped the consensus estimate of -$0.42 by $0.02. Quarterly revenue was reported to be $612 thousand, below analysts' expectations of $6.35 million. With a trailing EPS of -$1.73, Voyager Therapeutics' earnings are expected to grow next year, from ($1.58) to ($1.33) per share.

Latest Q3
Earnings Date
Nov. 5Estimated
Consensus EPS
(Nov. 5)
-$0.42
Actual EPS
(Nov. 5)
-$0.40 Beat By $0.02
Actual Revenue
(Nov. 5)
$0.61M

Q3 2026 Earnings Resources

Get Voyager Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Voyager Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

VYGR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VYGR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Voyager Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.28-$0.28-$0.28
Q2 20261-$0.48-$0.48-$0.48
Q3 20261-$0.29-$0.29-$0.29
Q4 20261-$0.17-$0.17-$0.17
FY 20264-$1.22-$1.22-$1.22
Q1 20271-$0.26-$0.26-$0.26
Q2 20271-$0.26-$0.26-$0.26
Q3 20271-$0.27-$0.27-$0.27
Q4 20271-$0.25-$0.25-$0.25
FY 20274-$1.04-$1.04-$1.04

Voyager Therapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026-$0.4188-$0.40+$0.0188-$0.40$6.35M$0.61M
8/6/2026Q2 2026-$0.4838-$0.40+$0.0838-$0.40$4.52M$3.17M
5/7/2026Q1 2026-$0.54-$0.47+$0.07-$0.47$8.79M$1.19M
3/9/2026Q4 2025-$0.54-$0.46+$0.08-$0.46$10.49M$13.46M
11/10/2025Q3 2025-$0.53-$0.47+$0.06-$0.47$7.86M$11.15M
8/6/2025Q2 2025-$0.48-$0.57 -$0.09-$0.57$9.50M$5.20M
5/6/2025Q1 2025-$0.35-$0.53 -$0.18-$0.53$13.55M$6.47M
3/11/2025Q4 2024-$0.35-$0.59 -$0.24-$0.59$16.58M$4.39M
11/12/2024Q3 2024-$0.45-$0.16+$0.29-$0.16$12.63M$24.63M

Voyager Therapeutics Earnings - Frequently Asked Questions

Voyager Therapeutics (NASDAQ:VYGR) last announced its quarterly earning data on Thursday, November 5, 2026. Learn more on VYGR's earnings history.

In the previous quarter, Voyager Therapeutics (NASDAQ:VYGR) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.42) by $0.02. Learn more on analysts' earnings estimate vs. VYGR's actual earnings.

Voyager Therapeutics (NASDAQ:VYGR) has a recorded annual revenue of $25.11 million.

Voyager Therapeutics (NASDAQ:VYGR) has a recorded net income of -$119.72 million. VYGR has generated -$1.73 earnings per share over the last four quarters.

Voyager Therapeutics' earnings are expected to grow from ($1.58) per share to ($1.33) per share in the next year.


Earnings data for NASDAQ:VYGR is sourced from Fiscal.ai, with the most recent quarter reported on 11/5/2026. New results are added as companies report their earnings.
From Our Partners